Two Sigma Investments’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-31,128
| Closed | -$1.05M | – | 4864 |
|
|
2025
Q4 | $1.05M | Sell |
31,128
-3,690
| -11% | -$115K | ﹤0.01% | 2875 |
|
|
2025
Q3 | $898K | Sell |
34,818
-8,803
| -20% | -$115K | ﹤0.01% | 2656 |
|
|
2025
Q2 | $349K | Sell |
43,621
-3,130
| -7% | -$23.9K | ﹤0.01% | 2734 |
|
|
2025
Q1 | $456K | Buy |
46,751
+24,193
| +107% | +$238K | ﹤0.01% | 2555 |
|
|
2024
Q4 | $285K | Sell |
22,558
-42,495
| -65% | -$540K | ﹤0.01% | 2752 |
|
|
2024
Q3 | $1.05M | Sell |
65,053
-11,485
| -15% | -$232K | ﹤0.01% | 2093 |
|
|
2024
Q2 | $1.87M | Buy |
76,538
+23,338
| +44% | +$1.08M | ﹤0.01% | 1599 |
|
|
2024
Q1 | $3.82M | Buy |
53,200
+49,120
| +1,204% | +$6.83M | 0.01% | 1113 |
|
|
2023
Q4 | $811K | Buy |
4,080
+1,705
| +72% | +$211K | ﹤0.01% | 2197 |
|
|
2023
Q3 | $316K | Sell |
2,375
-3,450
| -59% | -$563K | ﹤0.01% | 2472 |
|
|
2023
Q2 | $871K | Sell |
5,825
-2,145
| -27% | -$334K | ﹤0.01% | 2014 |
|
|
2023
Q1 | $1.17M | Buy |
7,970
+5,395
| +210% | +$1.09M | ﹤0.01% | 1781 |
|
|
2022
Q4 | $408K | Buy |
+2,575
| New | +$412K | ﹤0.01% | 2112 |
|
|
2022
Q3 | – | Sell |
-1,475
| Closed | -$215K | – | 2754 |
|
|
2022
Q2 | $215K | Sell |
1,475
-8,374
| -85% | -$1.12M | ﹤0.01% | 2135 |
|
|
2022
Q1 | $1.73M | Sell |
9,849
-7,341
| -43% | -$1.39M | 0.01% | 1423 |
|
|
2021
Q4 | $5.05M | Sell |
17,190
-9,227
| -35% | -$2.47M | 0.01% | 1191 |
|
|
2021
Q3 | $6.56M | Buy |
26,417
+1,060
| +4% | +$280K | 0.01% | 1030 |
|
|
2021
Q2 | $6.45M | Buy |
25,357
+21,219
| +513% | +$3.96M | 0.01% | 1044 |
|
|
2021
Q1 | $735K | Sell |
4,138
-1,350
| -25% | -$223K | ﹤0.01% | 2587 |
|
|
2020
Q4 | $867K | Buy |
5,488
+3,808
| +227% | +$828K | ﹤0.01% | 2114 |
|
|
2020
Q3 | $433K | Buy |
+1,680
| New | +$373K | ﹤0.01% | 2348 |
|
Two Sigma Investments's RAPT Position: Q1 2026 in Review
Two Sigma Investments sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 31,128 shares — an estimated $1.05M sold.
Two Sigma Investments first reported a position in RAPT in Q3 2020 and held it in 21 quarters. The position peaked at $6.56M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Two Sigma Investments reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 31,128 RAPT Therapeutics shares in Q1 2026, an estimated $1.05M.
- Two Sigma Investments first reported a position in RAPT Therapeutics in Q3 2020 and held it in 21 quarters.
- Two Sigma Investments's RAPT Therapeutics position peaked at $6.56M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.